---
title: "BrightGene: Termination of the issuance of A-shares to specific targets for the year 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261228512.md"
description: "BrightGene announced that the company has decided to terminate the issuance of A-shares to specific targets for the year 2024 and will apply to the Shanghai Stock Exchange to withdraw the relevant documents. This termination is based on a comprehensive consideration of the current market environment, the company's actual situation, and development plans, aiming to protect the interests of all shareholders, especially those of small and medium-sized investors"
datetime: "2025-10-15T10:15:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261228512.md)
  - [en](https://longbridge.com/en/news/261228512.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261228512.md)
generator: "portal-rs"
---

# BrightGene: Termination of the issuance of A-shares to specific targets for the year 2024

BrightGene announced that the company has decided to terminate the issuance of A-shares to specific targets for the year 2024 and will apply to the Shanghai Stock Exchange to withdraw the relevant documents. This termination is based on a comprehensive consideration of the current market environment, the company's actual situation, and development plans, aiming to protect the interests of all shareholders, especially those of small and medium-sized investors

### Related Stocks

- [688166.CN](https://longbridge.com/en/quote/688166.CN.md)

## Related News & Research

- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [Khan demands Burnham block Heathrow expansion over net zero](https://longbridge.com/en/news/297836820.md)
- [DHL partners local life sciences incubator to provide cold chain logistics for biotech startups](https://longbridge.com/en/news/298027232.md)
- [Biocytogen licenses fully human VHH antibody to Qilu Pharma in non-exclusive deal](https://longbridge.com/en/news/297781804.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**